These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19289240)

  • 21. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P; Eser D; Aicher S; Schüle C; Baghai TC; Padberg F; Ella R; Möller HJ; Rupprecht R
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test.
    Nardi AE; Lopes FL; Freire RC; Veras AB; Nascimento I; Valença AM; de-Melo-Neto VL; Soares-Filho GL; King AL; Araújo DM; Mezzasalma MA; Rassi A; Zin WA
    Psychiatry Res; 2009 Sep; 169(2):149-53. PubMed ID: 19698996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T; Erb G; Mathis A; Gilles C; Namer IJ; Hode Y; Demaziere A; Luthringer R; Macher JP
    Neuroimage; 2006 Jul; 31(3):1197-208. PubMed ID: 16600640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA; Koszycki D; Bradwejn J
    Depress Anxiety; 2004; 20(2):51-8. PubMed ID: 15390214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder.
    Strawn JR; D'Alessio DA; Keck PE; Seeley RJ
    J Psychiatr Res; 2008 Jul; 42(9):787-9. PubMed ID: 17888452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C; Jahn H; Kellner M; Yassouridis A; Wiedemann K
    World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D; Zacharko RM; Le Mellédo JM; Bradwejn J
    Depress Anxiety; 1998; 8(1):1-7. PubMed ID: 9750972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of a relationship between the pupillary light reflex response and state/trait anxiety in remitted patients with panic disorder.
    Shioiri T; Kuwabara H; Abe R; Iijima A; Kojima-Maruyama M; Kitamura H; Bando T; Someya T
    J Affect Disord; 2006 Oct; 95(1-3):159-64. PubMed ID: 16762420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenomenology of panic attacks: a descriptive study of panic disorder patients' self-reports.
    Aronson TA; Logue CM
    J Clin Psychiatry; 1988 Jan; 49(1):8-13. PubMed ID: 3335492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Panic attack symptom dimensions and their relationship to illness characteristics in panic disorder.
    Meuret AE; White KS; Ritz T; Roth WT; Hofmann SG; Brown TA
    J Psychiatr Res; 2006 Sep; 40(6):520-7. PubMed ID: 16293263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A; Holsboer F; Rupprecht R
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between serotonin-related gene polymorphisms and panic disorder.
    Yoon HK; Yang JC; Lee HJ; Kim YK
    J Anxiety Disord; 2008 Dec; 22(8):1529-34. PubMed ID: 18436425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smaller amygdala is associated with anxiety in patients with panic disorder.
    Hayano F; Nakamura M; Asami T; Uehara K; Yoshida T; Roppongi T; Otsuka T; Inoue T; Hirayasu Y
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):266-76. PubMed ID: 19566756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P; Eser D; Völkel N; Baghai TC; Möller HJ; Rupprecht R; Padberg F
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks.
    Eser D; Uhr M; Leicht G; Asmus M; Länger A; Schüle C; Baghai TC; Mulert C; Rupprecht R
    J Psychiatr Res; 2011 Jan; 45(1):60-3. PubMed ID: 20542521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of spontaneous panic attacks: a prospective study of risk factors.
    Coryell W; Dindo L; Fyer A; Pine DS
    Psychosom Med; 2006; 68(5):754-7. PubMed ID: 17012529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panic anxiety and hyperventilation in patients with chest pain: a controlled study.
    Bass C; Chambers JB; Kiff P; Cooper D; Gardner WN
    Q J Med; 1988 Dec; 69(260):949-59. PubMed ID: 3270082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ventilatory response to cholecystokinin tetrapeptide in healthy volunteers.
    Katzman MA; Duffin J; Shlik J; Bradwejn J
    Neuropsychopharmacology; 2002 Jun; 26(6):824-31. PubMed ID: 12007753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acute exercise on CO(2) -induced fear.
    Esquivel G; Dandachi A; Knuts I; Goossens L; Griez E; Schruers K
    Depress Anxiety; 2012 Feb; 29(2):155-8. PubMed ID: 21898704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.